BioCentury | Dec 4, 2019
Company News

Management tracks: Mittal to succeed Biocon’s Chandavarkar; plus Intercept, Nektar, Agios, Accelerate, ABPI and more

...Stanley Musial as CFO and CBO. Musial served as CFO of EryDel S.p.A., Egalet Corp., Strategic Diagnostics...
BioCentury | Jul 22, 2013
Company News

OriGene, SDIX deal

...OriGene completed its acquisition of substantially all of the assets of SDIX for $16 million. SDIX...
...net tax operating losses (see BioCentury, April 15). OriGene Technologies Inc. , Rockville, Md. SDIX (NASDAQ:SDIX...
BioCentury | Apr 15, 2013
Company News

OriGene, SDIX deal

...OriGene will acquire substantially all of the assets of SDIX for $16 million, including its Genomic...
...deal is expected to close this quarter, subject to approval of SDIX's shareholders. Last October, SDIX...
...life science business (see BioCentury, Oct. 8, 2012). OriGene Technologies Inc. , Rockville, Md. SDIX (NASDAQ:SDIX...
BioCentury | Oct 8, 2012
Company News

SDIX, Romer Labs deal

...on its life science business. SDIX discovers mAbs using its Genomic Antibody Technology (GAT). SDIX (NASDAQ:SDIX...
BioCentury | May 21, 2012
Company News

SDIX deal

...SDIX's Genomic Antibody Technology to discover mAbs against a GPCR target selected by the pharma. SDIX...
..."essential" to the development of one of the pharma's therapeutics. Details were not disclosed. SDIX (NASDAQ:SDIX...
BioCentury | Feb 13, 2012
Company News

Becton Dickinson, SDIX deal

...BD access to SDIX's antibody technology and a non-exclusive license to its bacteria phage technology. SDIX...
...front and is eligible for up to $2.5 million in milestones, plus royalties. Upon commercialization, SDIX...
...responsible for supplying antibodies to BD. Becton Dickinson and Co. (NYSE:BDX), Franklin Lakes, N.J. SDIX (NASDAQ:SDIX...
BioCentury | Feb 8, 2010
Company News

SDI management update

...Strategic Diagnostics Inc. (NASDAQ: SDIX ), Newark, Del. Business: Diagnostic Hired: Klaus Lindpaintner as VP of...
BioCentury | Jan 18, 2010
Company News

SDI management update

...Strategic Diagnostics Inc. (NASDAQ: SDIX ), Newark, Del. Business: Diagnostic Hired: Klaus Lindpaintner as CSO and...
BioCentury | Jan 11, 2010
Company News

SDI, Fred Hutchinson Cancer Research Center deal

...focus on pancreatic cancer. Strategic Diagnostics will provide the center with about 1,000 antibodies developed using Strategic Diagnostics'...
...will have an option to license any IP developed under the deal. Strategic Diagnostics Inc. (NASDAQ: SDIX...
BioCentury | Jun 1, 2009
Company News

SDI management update

...Strategic Diagnostics Inc. (NASDAQ: SDIX ), Newark, Del. Business: Diagnostic Hired: Kevin Bratton as VP of...
Items per page:
1 - 10 of 20
BioCentury | Dec 4, 2019
Company News

Management tracks: Mittal to succeed Biocon’s Chandavarkar; plus Intercept, Nektar, Agios, Accelerate, ABPI and more

...Stanley Musial as CFO and CBO. Musial served as CFO of EryDel S.p.A., Egalet Corp., Strategic Diagnostics...
BioCentury | Jul 22, 2013
Company News

OriGene, SDIX deal

...OriGene completed its acquisition of substantially all of the assets of SDIX for $16 million. SDIX...
...net tax operating losses (see BioCentury, April 15). OriGene Technologies Inc. , Rockville, Md. SDIX (NASDAQ:SDIX...
BioCentury | Apr 15, 2013
Company News

OriGene, SDIX deal

...OriGene will acquire substantially all of the assets of SDIX for $16 million, including its Genomic...
...deal is expected to close this quarter, subject to approval of SDIX's shareholders. Last October, SDIX...
...life science business (see BioCentury, Oct. 8, 2012). OriGene Technologies Inc. , Rockville, Md. SDIX (NASDAQ:SDIX...
BioCentury | Oct 8, 2012
Company News

SDIX, Romer Labs deal

...on its life science business. SDIX discovers mAbs using its Genomic Antibody Technology (GAT). SDIX (NASDAQ:SDIX...
BioCentury | May 21, 2012
Company News

SDIX deal

...SDIX's Genomic Antibody Technology to discover mAbs against a GPCR target selected by the pharma. SDIX...
..."essential" to the development of one of the pharma's therapeutics. Details were not disclosed. SDIX (NASDAQ:SDIX...
BioCentury | Feb 13, 2012
Company News

Becton Dickinson, SDIX deal

...BD access to SDIX's antibody technology and a non-exclusive license to its bacteria phage technology. SDIX...
...front and is eligible for up to $2.5 million in milestones, plus royalties. Upon commercialization, SDIX...
...responsible for supplying antibodies to BD. Becton Dickinson and Co. (NYSE:BDX), Franklin Lakes, N.J. SDIX (NASDAQ:SDIX...
BioCentury | Feb 8, 2010
Company News

SDI management update

...Strategic Diagnostics Inc. (NASDAQ: SDIX ), Newark, Del. Business: Diagnostic Hired: Klaus Lindpaintner as VP of...
BioCentury | Jan 18, 2010
Company News

SDI management update

...Strategic Diagnostics Inc. (NASDAQ: SDIX ), Newark, Del. Business: Diagnostic Hired: Klaus Lindpaintner as CSO and...
BioCentury | Jan 11, 2010
Company News

SDI, Fred Hutchinson Cancer Research Center deal

...focus on pancreatic cancer. Strategic Diagnostics will provide the center with about 1,000 antibodies developed using Strategic Diagnostics'...
...will have an option to license any IP developed under the deal. Strategic Diagnostics Inc. (NASDAQ: SDIX...
BioCentury | Jun 1, 2009
Company News

SDI management update

...Strategic Diagnostics Inc. (NASDAQ: SDIX ), Newark, Del. Business: Diagnostic Hired: Kevin Bratton as VP of...
Items per page:
1 - 10 of 20